Biomarin Pharmaceutical (BMRN)
95.00
-2.06 -2.12%
NASDAQ
Jun 23, 20:00
Delayed 2m
USD
View All Key Stats
BMRN Key Stats
| Income Statement | |
| Revenue (TTM) | 1.184B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -3.40 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -561.36M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 83.54% |
| Profit Margin (Quarterly) | -5.36% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00 |
| Price and Valuation | |
| Market Cap | 16.58B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 13.55 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 5.986 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.2495 |
| Free Cash Flow (Quarterly) | -149.53M |
| Return on Equity (TTM) | -22.66% |
View All BMRN News
BMRN News
-
WireHeadlineTime (ET)
-
Yahoo06/25 21:54
-
Yahoo06/25 16:49
-
PR Newswire06/23 06:00
-
Yahoo06/22 08:37
-
MT Newswires06/21 16:52
-
MT Newswires06/16 12:28
-
Yahoo06/16 08:38
-
PR Newswire06/16 08:31
-
Yahoo06/15 13:18
-
Yahoo06/14 09:45
View All Events
BMRN Events
| Date | Type | Description |
|---|---|---|
| 06/06/2017 09:00 PDT | Misc | Biomarin Pharmaceutical Inc Annual General Meeting in 2016 |
| 05/04/2017 | Misc | Biomarin Pharmaceutical Inc First Quarter Earnings Conference Call in 2017 |
| 05/04/2017 | Earnings | Biomarin Pharmaceutical Inc First Quarter Earnings in 2017 Release |
| 02/23/2017 16:30 EDT | Misc | Biomarin Pharmaceutical Inc Fourth Quarter Earnings Conference Call in 2016 |
| 02/23/2017 | Earnings | Biomarin Pharmaceutical Inc Fourth Quarter Earnings in 2016 Release |
| 10/27/2016 16:30 EDT | Misc | Biomarin Pharmaceutical Inc Third Quarter Earnings Conference Call in 2016 |
| 10/27/2016 | Earnings | Biomarin Pharmaceutical Inc Third Quarter Earnings in 2016 Release |
| 08/04/2016 16:30 EDT | Misc | Biomarin Pharmaceutical Inc Second Quarter Earnings Conference Call in 2016 |
| 08/04/2016 | Earnings | Biomarin Pharmaceutical Inc Second Quarter Earnings in 2016 Release |
BMRN Fundamentals
Income Statement View Statement
BMRN Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
BMRN One Page Reports
- One Page Report Download
BMRN Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 95.00 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.bmrn.com
- Investor Relations URL: http://investors.bmrn.com/
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: May. 04, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Biomarin Pharmaceutical Inc is on rare-disease therapies. It develops and commercializes pharmaceuticals for serious diseases and medical conditions.
BMRN Comparables
EditBMRN Excel Add-In Codes
- Name: =YCI("BMRN","name")
- Description: =YCI("BMRN","description")
- Sector: =YCI("BMRN","sector")
- Industry: =YCI("BMRN","industry")
- Est. Current Fiscal Year End: =YCI("BMRN","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other BMRN Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- BMRN Tweets Stocktwits
Advertisement
